OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
BFER55

Bharat Agri Fert & Realty Ltd

Agricultural ChemicalsVerified

Bharat Agri Fert & Realty Ltd exhibits a debt-to-equity ratio of 0.91, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 2.02, suggesting it can cover short-term obligations but with limited buffer. However, the operating cash flow of -147.67 million INR indicates a cash outflow from operations, which may pressure liquidity in the near term. Profitability metrics show mixed results. The company's return on equity (ROE) is 11.08%, which is strong, but its return on assets (ROA) is only 5.07%, indicating that asset utilization is not as efficient. The net income of 54.66 million INR contrasts with an operating loss of 8.35 million INR, suggesting non-operating income or gains are driving profitability. This divergence may raise questions about the sustainability of earnings. The company's revenue is concentrated in a single business segment, as disclosed segments are not available in the provided data. Geographically, the company's exposure is primarily to India, with no material international operations disclosed. This concentration may increase vulnerability to domestic economic or regulatory shifts. Growth trajectory appears uncertain. The company's operating income has turned negative, and while revenue is reported at 503.51 million INR, there is no clear indication of year-over-year growth. The capital expenditure of -49.15 million INR suggests a reduction in investment, which may signal a strategic shift or financial constraint. Risk factors include liquidity concerns due to negative net cash after subtracting total debt. The dilution risk is assessed as low, with no significant dilution sources identified in the risk assessment. However, the company's operating cash flow and capital expenditure trends may require monitoring for potential future dilution pressures. Recent events include the latest financial filing (HA-latest), which provides the most recent financial data. No recent earnings call transcripts or material regulatory filings are available in the provided data, limiting insight into management commentary or strategic direction.

30-day price · BFER+6.35 (+28.0%)
Low$20.30High$32.00Close$29.06As of17 May, 00:00 UTC
Profile
CompanyBharat Agri Fert & Realty Ltd
TickerBFER.BO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. Bharat Agri Fert & Realty Ltd operates in the agricultural chemicals industry, producing and distributing chemical products for agricultural use.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Agricultural Chemicals industry with a confidence level of 0.92.

Bharat Agri Fert & Realty Ltd exhibits a debt-to-equity ratio of 0.91, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 2.02, suggesting it can cover short-term obligations but with limited buffer. However, the operating cash flow of -147.67 million INR indicates a cash outflow from operations, which may pressure liquidity in the near term. Profitability metrics show mixed results. The company's return on equity (ROE) is 11.08%, which is strong, but its return on assets (ROA) is only 5.07%, indicating that asset utilization is not as efficient. The net income of 54.66 million INR contrasts with an operating loss of 8.35 million INR, suggesting non-operating income or gains are driving profitability. This divergence may raise questions about the sustainability of earnings. The company's revenue is concentrated in a single business segment, as disclosed segments are not available in the provided data. Geographically, the company's exposure is primarily to India, with no material international operations disclosed. This concentration may increase vulnerability to domestic economic or regulatory shifts. Growth trajectory appears uncertain. The company's operating income has turned negative, and while revenue is reported at 503.51 million INR, there is no clear indication of year-over-year growth. The capital expenditure of -49.15 million INR suggests a reduction in investment, which may signal a strategic shift or financial constraint. Risk factors include liquidity concerns due to negative net cash after subtracting total debt. The dilution risk is assessed as low, with no significant dilution sources identified in the risk assessment. However, the company's operating cash flow and capital expenditure trends may require monitoring for potential future dilution pressures. Recent events include the latest financial filing (HA-latest), which provides the most recent financial data. No recent earnings call transcripts or material regulatory filings are available in the provided data, limiting insight into management commentary or strategic direction.
Key takeaways
  • The company's strong ROE of 11.08% is offset by a weak ROA of 5.07%, indicating inefficiencies in asset utilization.
  • Liquidity is medium, with a current ratio of 2.02, but negative operating cash flow raises concerns.
  • The debt-to-equity ratio of 0.91 suggests moderate leverage, but negative net cash after debt highlights liquidity risk.
  • Revenue concentration in a single segment and geographic exposure to India increase vulnerability to domestic economic shifts.
  • Growth appears constrained, with no clear year-over-year revenue growth and reduced capital expenditure.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$50.4M
Gross profit$40.5M
Operating income-$8.3M
Net income$54.7M
R&D
SG&A
D&A
SBC
Operating cash flow-$147.7M
CapEx-$49.2M
Free cash flow
Total assets$1.08B
Total liabilities$585.7M
Total equity$493.2M
Cash & equivalents
Long-term debt$451.2M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$256.7M-$45.7M-$59.4M-$113.0M
FY-3$230.1M-$7.2M$4.3M-$66.6M
FY-2$292.3M-$55.9M-$82.5M-$108.4M
FY-1$222.6M-$84.5M-$32.0M-$42.7M
FY0$253.5M-$18.4M$9.2M-$92.6M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$946.4M$600.6M
FY-3$993.4M$606.5M
FY-2$955.9M$527.0M
FY-1$1.08B$493.2M$10.0M
FY0$1.47B$504.2M$0.00
PeriodOCFCapExFCFSBC
FY-4$94.8M-$76.8M-$113.0M
FY-3$75.2M-$98.2M-$66.6M
FY-2$52.4M-$59.1M-$108.4M
FY-1-$147.7M-$49.2M-$42.7M
FY0-$75.8M-$144.1M-$92.6M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$50.4M-$8.3M$54.7M
FQ-6$55.5M-$7.5M-$501.0k
FQ-5$65.7M-$16.6M-$22.7M
FQ-4$61.7M-$15.2M-$10.3M
FQ-3$70.6M$13.2M$42.7M
FQ-2$55.6M$3.4M-$3.4M
FQ-1$53.8M-$5.2M-$20.4M
FQ0$53.5M-$23.7M-$38.8M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$1.08B$493.2M
FQ-6
FQ-5$1.26B$466.2M
FQ-4
FQ-3$1.47B$504.2M
FQ-2
FQ-1$1.80B$481.4M
FQ0
PeriodOCFCapExFCFSBC
FQ-7-$147.7M-$49.2M
FQ-6
FQ-5-$62.5M-$80.5M
FQ-4
FQ-3-$75.8M-$144.1M
FQ-2
FQ-1$132.3M-$161.3M
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$493.2M
Net cash-$451.2M
Current ratio2.0
Debt/Equity0.9
ROA5.1%
ROE11.1%
Cash conversion-2.7%
CapEx/Revenue-97.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricBFERActivity
Op margin-16.6%5.5% medp25 -0.0% · p75 10.8%bottom quartile
Net margin108.6%4.1% medp25 0.1% · p75 8.8%top quartile
Gross margin80.4%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-97.6%-6.2% medp25 -13.4% · p75 -2.6%bottom quartile
Debt / equity91.0%37.1% medp25 10.3% · p75 82.0%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-02 02:20 UTC#5815d957
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 11:50 UTCJob: 25369614